Disc Medicine (IRON) Total Current Liabilities (2020 - 2026)
Disc Medicine (IRON) reported Total Current Liabilities of $31.1 million for Q1 2026, up 66.17% year-over-year from $18.7 million in Q1 2025, and down 15.01% quarter-over-quarter from $36.6 million in Q4 2025.
Disc Medicine (IRON) Total Current Liabilities (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Total Current Liabilities data on file, last reported at $31.1 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $31.1 million, up 66.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.1 million (up 66.17% YoY), and the FY2025 annual result was $36.6 million, up 57.15% from the prior year.
- Total Current Liabilities slipped to $31.1 million in Q1 2026 per IRON's latest filing, from $36.6 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $36.6 million in Q4 2025 and troughed at $1.5 million in Q3 2022.
- A 5-year average of $18.6 million and a median of $20.3 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities tumbled 88.44% in 2022, then jumped 884.7% in 2023.
- A 5-year view of Total Current Liabilities shows it stood at $22.6 million in 2022, then fell by 5.04% to $21.4 million in 2023, then climbed by 8.76% to $23.3 million in 2024, then surged by 57.15% to $36.6 million in 2025, then retreated by 15.01% to $31.1 million in 2026.
- Business Quant data shows IRON's Total Current Liabilities at $31.1 million in Q1 2026, $36.6 million in Q4 2025, and $26.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | 31.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.14 Mn |
| Dec 31, 2025 | 36.64 Mn |
| Sep 30, 2025 | 26.74 Mn |
| Jun 30, 2025 | 20.61 Mn |
| Mar 31, 2025 | 18.74 Mn |
| Dec 31, 2024 | 23.32 Mn |
| Sep 30, 2024 | 25.47 Mn |
| Jun 30, 2024 | 20.31 Mn |
| Mar 31, 2024 | 14.85 Mn |
| Dec 31, 2023 | 21.44 Mn |
| Sep 30, 2023 | 14.42 Mn |
| Jun 30, 2023 | 9.68 Mn |
| Mar 31, 2023 | 9.98 Mn |
| Dec 31, 2022 | 22.58 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 13.42 Mn |
| Sep 30, 2021 | 12.66 Mn |
| Jun 30, 2021 | 11.51 Mn |